OR WAIT 15 SECS
© 2020 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
Exploring new character benchmarks for today’s pharma executives, and whether they have the transformational traits to lead through change.
Outlining the new leadership and C-level roles of tomorrow needed to take on the disruption event on pharma's horizon.
Biopharma’s diversity commitment remains a work in progress but the benefits-in measurable ROI-are increasingly clear.
For those companies in this year's Pharm Exec Top 50, meeting the accelerating market demand for specialty products has become an acute strategic imperative.